Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines

Abstract

Peer reviewed

David Bauer, Alexa Michel, Spencer Kaminsky, Mengshi Li, Michael Schultz, Shefali Saini, Suzanne Lapi and Jason Lewis

Nuclear medicine and biology, Vol.114-115(Suppl.), pp.S28-S29

11/01/2022

DOI: 10.1016/s0969-8051(22)02149-7

View Online

Radiology, Nuclear Medicine and imaging

Cancer Research

Molecular Medicine

Title: Subtitle: Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines
Creators: David Bauer
Alexa Michel
Spencer Kaminsky
Mengshi Li
Michael Schultz
Shefali Saini
Suzanne Lapi
Jason Lewis
Resource Type: Abstract
Publication Details: Nuclear medicine and biology, Vol.114-115(Suppl.), pp.S28-S29
Publisher: Elsevier BV
DOI: 10.1016/s0969-8051(22)02149-7
ISSN: 0969-8051
eISSN: 1872-9614
Language: English
Date published: 11/01/2022
Academic Unit: Radiology; Radiation Oncology
Record Identifier: 9984530262602771

2 Record Views